Effects of long-term administration of Tegafur on patients with relapsing advanced carcinoma (stage D) of the prostate

Effects of long-term administration of Tegafur on patients with relapsing advanced carcinoma (stage D) of the prostate

Daily 600 mg of Tegafur, in addition to antiandrogen therapy, was administered to 20 patients with relapsing prostatic carcinoma at stage D. Thirteen of the patients died and 7 patients are still alive. These patients were evaluated according to the objective response criteria of NPCP . Three patien...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 29(1983), 1 vom: 15. Jan., Seite 105-11
1. Verfasser: Yoshida, K (VerfasserIn)
Weitere Verfasser: Negishi, T, Kobayashi, N, Saito, T, Owada, F, Ajima, J, Satake, I, Tari, K
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1983
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:English Abstract Journal Article Estrogens Tegafur 1548R74NSZ Fluorouracil U3P01618RT